February 4, 2016

Celldex Therapeutics to Present at the Leerink Partners 5th Annual Global Healthcare Conference

HAMPTON, N.J., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that Anthony Marucci, Co-founder, President and Chief Executive Officer, and Thomas Davis, M.D., Executive Vice President and Chief Medical Officer, will participate in a fireside chat at the Leerink Partners 5th Annual Global Healthcare Conference on Thursday, February 11, 2016 at 2:40 p.m. EST in New York City.

The live webcast of the presentation will be available on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. A replay of the presentation will be available for seven days following the event.

About Celldex Therapeutics, Inc.
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response. Visit www.celldex.com

Contact

Sarah Cavanaugh

Vice President of Investor Relations & Corp Communications

Celldex Therapeutics, Inc.

(781) 433-3161

scavanaugh@celldex.com 

Primary Logo

Source: Celldex Therapeutics, Inc.

News Provided by Acquire Media


Close window | Back to top

Copyright 2017 Celldex Therapeutics, Inc.